Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Mount Sinai Rehabilitation Hospital
With
Brown University
Acorda Therapeutics
Subjects will be evaluated before starting medication, throughout a 14week period after starting D-ER as well as at 12 and 18months following the start date of medication regardless of if they stayed on medication or not.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Confirmed clinical diagnosis of MS by McDonald criteria
Prescribed ampyra (dalfampridine) as part of usual care, but have not yet started taking the medication before baseline visit
Receive MS care at the Mandell MS center
Cognitively able to understand directions and complete protocol (score of 22 or greater on the MMSE)
18 years of age or older
You may not be if
Already began to take drug prior to baseline research visit
Not planning to continue care at Mandell Center for at least 14 weeks after initiation of therapy
